Therapeutic vaccines are biological drugs used for the treatment of various chronic medical conditions such as cancer, infections diseases, and autoimmune disorders. Therapeutic vaccines work by helping the immune system recognize and destroy cancer cells or fight chronic infections. Some key areas where therapeutic vaccines are used include infectious diseases like HIV, hepatitis B, hepatitis C, herpes, malaria and tuberculosis. They are also used for cancer indications like melanoma, prostate cancer, lymphoma and leukemia.

The global therapeutic vaccines market is estimated to be valued at US$ 2.68 Bn in 2023 and is expected to exhibit a CAGR of 3.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
Rising prevalence of chronic diseases is a major driver boosting growth of the therapeutic vaccines market. According to the World Health Organization (WHO), chronic diseases accounted for approximately 60% of global deaths in 2001, with cancer, heart disease, stroke and respiratory diseases being the leading cause of mortality. Therapeutic vaccines provide effective long term disease management by empowering the immune system to fight against chronic conditions. This reduces healthcare costs associated with repeated hospital visits and medication. Moreover, advancement in vaccine designing techniques along with increasing R&D investments from pharmaceutical companies is also fueling market growth. However, high costs of development and regulatory delays remain a challenge for widespread adoption of therapeutic vaccines.

SWOT Analysis

Strength: Therapeutic vaccines offer long-term benefits along with less side effects compared to other therapeutics. This provides a better treatment option for chronic diseases. Researchers are actively developing advanced technologies that could help overcome existing limitations with therapeutic vaccines.

Weakness: High development costs and strict regulatory norms associated with therapeutic vaccines increase the risks involved. Long development cycles also delay commercialization. Therapeutic vaccines often show variable responses among patients due to complex disease mechanisms.

Opportunity: Rising prevalence of cancer and infectious diseases globally presents a massive market opportunity. Significant unmet needs in HIV, tuberculosis, and respiratory diseases indicate scopes for innovations. Collaborations between developers and funding from public-private partnerships could help expedite clinical research.

Threats: Stiff competition from existing drug therapies poses pricing challenges. Safety concerns over new technologies may impact patient uptake in the initial years. Unforeseen failures in late-stage trials also undermine return on investments.

Key Takeaways

The Global Therapeutic Vaccines Market Demand is expected to witness high growth on account of rising disease burdens and growing fund supports for vaccine innovations. According to estimates, the market was valued at US$ 2.68 Bn in 2024 and is projected to reach over US$ 3.5 Bn by 2030, expanding at a CAGR of 3.5% during the forecast period.

Regional analysis: North America currently dominates the global market owing to rapid adoption of novel vaccines and strong in-house manufacturing capabilities in the US and Canada. The region accounted for over 35% revenue share in 2024. Asia Pacific is anticipated to emerge as the fastest growing regional market through 2030 supported by increasing healthcare expenditures, developing production capacities in India and China, and rising public-private initiatives to boost domestic vaccine production.

Key players: Key players operating in the therapeutic vaccines market are AMR India Limited, GlaxoSmithKline plc, CEL-SCI Corporation, Moderna, Inc., BioNTech SE, IBIO, INC., Nouscom, Oxford BioMedica, GEOVax Labs, Inc., and PDS Biotechnology Corporation. These players have undertaken strategic collaborations as well as product development initiatives to consolidate their market presence.

Get more insights on this topic: https://www.ukwebwire.com/therapeutic-vaccines-market-demand-share-analysis/